APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Drug Raw Materials

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Drug Raw Materials Market Outlook and Growth Opportunities 2026

27 December 2025209 pages

Choose your research edition.

Industry ResearchVeterinary Drug Raw Materials Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Drug Raw Materials Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Veterinary Drug Raw Materials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Drug Raw Materials Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Drug Raw Materials Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Veterinary Drug Raw Materials market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Drug Raw Materials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Drug Raw Materials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Drug Raw Materials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Drug Raw Materials market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Drug Raw Materials market include China Animal Husbandry Co., Ltd., victory creature, Shandong Lukang, Rip Biotech, Qilu Pharmaceutical, Qihui Pharmaceutical, Puluo Pharmaceutical, LianBern Pharmaceuticals and Jiangsu Tianhe Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Drug Raw Materials market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Drug Raw Materials and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Drug Raw Materials sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Drug Raw Materials market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Drug Raw Materials Segment by Company

China Animal Husbandry Co., Ltd.

victory creature

Shandong Lukang

Rip Biotech

Qilu Pharmaceutical

Qihui Pharmaceutical

Puluo Pharmaceutical

LianBern Pharmaceuticals

Jiangsu Tianhe Pharmaceutical

Lasa Supergenerics Limited

Menadiona, S. L

SeQuent Scientific Limited

Guobang Pharmaceutical

Haisheng Pharmaceutical

Hanjiang Pharmaceutical

Hui Sheng Biology

Jiuzhou Pharmaceutical

Xinhua Pharmaceutical

Shreeji Pharma Internationa

Veterinary Drug Raw Materials Segment by Type

Antipyretic, Analgesic and Anti-inflammatory Drugs

Antiparasitic Drugs

Antimicrobials

Other

Veterinary Drug Raw Materials Segment by Application

Livestock Industrial

Pet Industry

Veterinary Drug Raw Materials Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Drug Raw Materials status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Drug Raw Materials market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Drug Raw Materials significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Drug Raw Materials competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drug Raw Materials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Drug Raw Materials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drug Raw Materials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Drug Raw Materials market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Drug Raw Materials industry.

Chapter 3: Detailed analysis of Veterinary Drug Raw Materials manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Drug Raw Materials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Drug Raw Materials in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Drug Raw Materials Industry Trends Table 2. Veterinary Drug Raw Materials Industry Drivers Table 3. Veterinary Drug Raw Materials Industry Opportunities and Challenges Table 4. Veterinary Drug Raw Materials Industry Restraints Table 5. Global Veterinary Drug Raw Materials Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Drug Raw Materials Revenue Share by Company (2021-2026) Table 7. Global Veterinary Drug Raw Materials Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Veterinary Drug Raw Materials Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Drug Raw Materials Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Veterinary Drug Raw Materials Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Drug Raw Materials Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Drug Raw Materials Company, Product Type & Application Table 13. Global Veterinary Drug Raw Materials Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Drug Raw Materials by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antipyretic, Analgesic and Anti-inflammatory Drugs Table 18. Significant Companies of Antiparasitic Drugs Table 19. Significant Companies of Antimicrobials Table 20. Significant Companies of Other Table 21. Global Veterinary Drug Raw Materials Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Veterinary Drug Raw Materials Sales Volume by Type (2021-2026) & (Tons) Table 23. Global Veterinary Drug Raw Materials Sales Volume by Type (2027-2032) & (Tons) Table 24. Global Veterinary Drug Raw Materials Sales Volume Share by Type (2021-2026) Table 25. Global Veterinary Drug Raw Materials Sales Volume Share by Type (2027-2032) Table 26. Global Veterinary Drug Raw Materials Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Veterinary Drug Raw Materials Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Veterinary Drug Raw Materials Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Veterinary Drug Raw Materials Sales Value Share by Type (2021-2026) Table 30. Global Veterinary Drug Raw Materials Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Livestock Industrial Table 32. Significant Companies of Pet Industry Table 33. Global Veterinary Drug Raw Materials Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Veterinary Drug Raw Materials Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Veterinary Drug Raw Materials Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Veterinary Drug Raw Materials Sales Volume Share by Application (2021-2026) Table 37. Global Veterinary Drug Raw Materials Sales Volume Share by Application (2027-2032) Table 38. Global Veterinary Drug Raw Materials Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Veterinary Drug Raw Materials Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Veterinary Drug Raw Materials Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Veterinary Drug Raw Materials Sales Value Share by Application (2021-2026) Table 42. Global Veterinary Drug Raw Materials Sales Value Share by Application (2027-2032) Table 43. Global Veterinary Drug Raw Materials Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Veterinary Drug Raw Materials Sales by Region (2021-2026) & (Tons) Table 45. Global Veterinary Drug Raw Materials Sales Market Share by Region (2021-2026) Table 46. Global Veterinary Drug Raw Materials Sales by Region (2027-2032) & (Tons) Table 47. Global Veterinary Drug Raw Materials Sales Market Share by Region (2027-2032) Table 48. Global Veterinary Drug Raw Materials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Veterinary Drug Raw Materials Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Veterinary Drug Raw Materials Sales Value Share by Region (2021-2026) Table 51. Global Veterinary Drug Raw Materials Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Veterinary Drug Raw Materials Sales Value Share by Region (2027-2032) Table 53. Global Veterinary Drug Raw Materials Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Veterinary Drug Raw Materials Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Veterinary Drug Raw Materials Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Veterinary Drug Raw Materials Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Veterinary Drug Raw Materials Sales by Country (2021-2026) & (Tons) Table 58. Global Veterinary Drug Raw Materials Sales Market Share by Country (2021-2026) Table 59. Global Veterinary Drug Raw Materials Sales by Country (2027-2032) & (Tons) Table 60. Global Veterinary Drug Raw Materials Sales Market Share by Country (2027-2032) Table 61. Global Veterinary Drug Raw Materials Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Veterinary Drug Raw Materials Sales Value Market Share by Country (2021-2026) Table 63. Global Veterinary Drug Raw Materials Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Veterinary Drug Raw Materials Sales Value Market Share by Country (2027-2032) Table 65. China Animal Husbandry Co., Ltd. Company Information Table 66. China Animal Husbandry Co., Ltd. Business Overview Table 67. China Animal Husbandry Co., Ltd. Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. China Animal Husbandry Co., Ltd. Veterinary Drug Raw Materials Product Portfolio Table 69. China Animal Husbandry Co., Ltd. Recent Development Table 70. victory creature Company Information Table 71. victory creature Business Overview Table 72. victory creature Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. victory creature Veterinary Drug Raw Materials Product Portfolio Table 74. victory creature Recent Development Table 75. Shandong Lukang Company Information Table 76. Shandong Lukang Business Overview Table 77. Shandong Lukang Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Shandong Lukang Veterinary Drug Raw Materials Product Portfolio Table 79. Shandong Lukang Recent Development Table 80. Rip Biotech Company Information Table 81. Rip Biotech Business Overview Table 82. Rip Biotech Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Rip Biotech Veterinary Drug Raw Materials Product Portfolio Table 84. Rip Biotech Recent Development Table 85. Qilu Pharmaceutical Company Information Table 86. Qilu Pharmaceutical Business Overview Table 87. Qilu Pharmaceutical Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Qilu Pharmaceutical Veterinary Drug Raw Materials Product Portfolio Table 89. Qilu Pharmaceutical Recent Development Table 90. Qihui Pharmaceutical Company Information Table 91. Qihui Pharmaceutical Business Overview Table 92. Qihui Pharmaceutical Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Qihui Pharmaceutical Veterinary Drug Raw Materials Product Portfolio Table 94. Qihui Pharmaceutical Recent Development Table 95. Puluo Pharmaceutical Company Information Table 96. Puluo Pharmaceutical Business Overview Table 97. Puluo Pharmaceutical Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Puluo Pharmaceutical Veterinary Drug Raw Materials Product Portfolio Table 99. Puluo Pharmaceutical Recent Development Table 100. LianBern Pharmaceuticals Company Information Table 101. LianBern Pharmaceuticals Business Overview Table 102. LianBern Pharmaceuticals Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. LianBern Pharmaceuticals Veterinary Drug Raw Materials Product Portfolio Table 104. LianBern Pharmaceuticals Recent Development Table 105. Jiangsu Tianhe Pharmaceutical Company Information Table 106. Jiangsu Tianhe Pharmaceutical Business Overview Table 107. Jiangsu Tianhe Pharmaceutical Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Jiangsu Tianhe Pharmaceutical Veterinary Drug Raw Materials Product Portfolio Table 109. Jiangsu Tianhe Pharmaceutical Recent Development Table 110. Lasa Supergenerics Limited Company Information Table 111. Lasa Supergenerics Limited Business Overview Table 112. Lasa Supergenerics Limited Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Lasa Supergenerics Limited Veterinary Drug Raw Materials Product Portfolio Table 114. Lasa Supergenerics Limited Recent Development Table 115. Menadiona, S. L Company Information Table 116. Menadiona, S. L Business Overview Table 117. Menadiona, S. L Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Menadiona, S. L Veterinary Drug Raw Materials Product Portfolio Table 119. Menadiona, S. L Recent Development Table 120. SeQuent Scientific Limited Company Information Table 121. SeQuent Scientific Limited Business Overview Table 122. SeQuent Scientific Limited Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. SeQuent Scientific Limited Veterinary Drug Raw Materials Product Portfolio Table 124. SeQuent Scientific Limited Recent Development Table 125. Guobang Pharmaceutical Company Information Table 126. Guobang Pharmaceutical Business Overview Table 127. Guobang Pharmaceutical Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. Guobang Pharmaceutical Veterinary Drug Raw Materials Product Portfolio Table 129. Guobang Pharmaceutical Recent Development Table 130. Haisheng Pharmaceutical Company Information Table 131. Haisheng Pharmaceutical Business Overview Table 132. Haisheng Pharmaceutical Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. Haisheng Pharmaceutical Veterinary Drug Raw Materials Product Portfolio Table 134. Haisheng Pharmaceutical Recent Development Table 135. Hanjiang Pharmaceutical Company Information Table 136. Hanjiang Pharmaceutical Business Overview Table 137. Hanjiang Pharmaceutical Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 138. Hanjiang Pharmaceutical Veterinary Drug Raw Materials Product Portfolio Table 139. Hanjiang Pharmaceutical Recent Development Table 140. Hui Sheng Biology Company Information Table 141. Hui Sheng Biology Business Overview Table 142. Hui Sheng Biology Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 143. Hui Sheng Biology Veterinary Drug Raw Materials Product Portfolio Table 144. Hui Sheng Biology Recent Development Table 145. Jiuzhou Pharmaceutical Company Information Table 146. Jiuzhou Pharmaceutical Business Overview Table 147. Jiuzhou Pharmaceutical Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 148. Jiuzhou Pharmaceutical Veterinary Drug Raw Materials Product Portfolio Table 149. Jiuzhou Pharmaceutical Recent Development Table 150. Xinhua Pharmaceutical Company Information Table 151. Xinhua Pharmaceutical Business Overview Table 152. Xinhua Pharmaceutical Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 153. Xinhua Pharmaceutical Veterinary Drug Raw Materials Product Portfolio Table 154. Xinhua Pharmaceutical Recent Development Table 155. Shreeji Pharma Internationa Company Information Table 156. Shreeji Pharma Internationa Business Overview Table 157. Shreeji Pharma Internationa Veterinary Drug Raw Materials Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 158. Shreeji Pharma Internationa Veterinary Drug Raw Materials Product Portfolio Table 159. Shreeji Pharma Internationa Recent Development Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Veterinary Drug Raw Materials Distributors List Table 163. Veterinary Drug Raw Materials Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Veterinary Drug Raw Materials Product Image Figure 2. Global Veterinary Drug Raw Materials Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Drug Raw Materials Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Drug Raw Materials Sales (2021-2032) & (Tons) Figure 5. Global Veterinary Drug Raw Materials Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Veterinary Drug Raw Materials Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antipyretic, Analgesic and Anti-inflammatory Drugs Image Figure 10. Antiparasitic Drugs Image Figure 11. Antimicrobials Image Figure 12. Other Image Figure 13. Global Veterinary Drug Raw Materials Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Veterinary Drug Raw Materials Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Veterinary Drug Raw Materials Sales Volume Share by Type (2021-2032) Figure 16. Global Veterinary Drug Raw Materials Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Veterinary Drug Raw Materials Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Veterinary Drug Raw Materials Sales Value Share by Type (2021-2032) Figure 19. Livestock Industrial Image Figure 20. Pet Industry Image Figure 21. Global Veterinary Drug Raw Materials Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Veterinary Drug Raw Materials Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Veterinary Drug Raw Materials Sales Volume Share by Application (2021-2032) Figure 24. Global Veterinary Drug Raw Materials Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Veterinary Drug Raw Materials Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Veterinary Drug Raw Materials Sales Value Share by Application (2021-2032) Figure 27. Global Veterinary Drug Raw Materials Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Veterinary Drug Raw Materials Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Veterinary Drug Raw Materials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Veterinary Drug Raw Materials Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Veterinary Drug Raw Materials Sales Value (2021-2032) & (US$ Million) Figure 32. North America Veterinary Drug Raw Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Veterinary Drug Raw Materials Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Veterinary Drug Raw Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Veterinary Drug Raw Materials Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Veterinary Drug Raw Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Veterinary Drug Raw Materials Sales Value (2021-2032) & (US$ Million) Figure 38. South America Veterinary Drug Raw Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Veterinary Drug Raw Materials Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Veterinary Drug Raw Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Veterinary Drug Raw Materials Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Veterinary Drug Raw Materials Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Antipyretic, Analgesic and Anti-inflammatory Drugs
  • Antiparasitic Drugs
  • Antimicrobials
  • Other
Applications
  • Livestock Industrial
  • Pet Industry
Companies covered
  • China Animal Husbandry Co., Ltd.
  • victory creature
  • Shandong Lukang
  • Rip Biotech
  • Qilu Pharmaceutical
  • Qihui Pharmaceutical
  • Puluo Pharmaceutical
  • LianBern Pharmaceuticals
  • Jiangsu Tianhe Pharmaceutical
  • Lasa Supergenerics Limited
  • Menadiona, S. L
  • SeQuent Scientific Limited
  • Guobang Pharmaceutical
  • Haisheng Pharmaceutical
  • Hanjiang Pharmaceutical
  • Hui Sheng Biology
  • Jiuzhou Pharmaceutical
  • Xinhua Pharmaceutical
  • Shreeji Pharma Internationa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Drug Raw Materials Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Drug Raw Materials Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Drug Raw Materials Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Drug Raw Materials Market Dynamics
  1. 2.1 Veterinary Drug Raw Materials Industry Trends
  2. 2.2 Veterinary Drug Raw Materials Industry Drivers
  3. 2.3 Veterinary Drug Raw Materials Industry Opportunities and Challenges
  4. 2.4 Veterinary Drug Raw Materials Industry Restraints
3 Veterinary Drug Raw Materials Market by Company
  1. 3.1 Global Veterinary Drug Raw Materials Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Drug Raw Materials Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Drug Raw Materials Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Drug Raw Materials Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Drug Raw Materials Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Drug Raw Materials Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Drug Raw Materials Company Product Type and Application
  8. 3.8 Global Veterinary Drug Raw Materials Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Drug Raw Materials Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Drug Raw Materials Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Drug Raw Materials Market by Type
  1. 4.1 Veterinary Drug Raw Materials Type Introduction
  2. 4.1.1 Antipyretic, Analgesic and Anti-inflammatory Drugs
  3. 4.1.2 Antiparasitic Drugs
  4. 4.1.3 Antimicrobials
  5. 4.1.4 Other
  6. 4.2 Global Veterinary Drug Raw Materials Sales Volume by Type
  7. 4.2.1 Global Veterinary Drug Raw Materials Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Veterinary Drug Raw Materials Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Veterinary Drug Raw Materials Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Veterinary Drug Raw Materials Sales Value by Type
  11. 4.3.1 Global Veterinary Drug Raw Materials Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Veterinary Drug Raw Materials Sales Value by Type (2021-2032)
  13. 4.3.3 Global Veterinary Drug Raw Materials Sales Value Share by Type (2021-2032)
5 Veterinary Drug Raw Materials Market by Application
  1. 5.1 Veterinary Drug Raw Materials Application Introduction
  2. 5.1.1 Livestock Industrial
  3. 5.1.2 Pet Industry
  4. 5.2 Global Veterinary Drug Raw Materials Sales Volume by Application
  5. 5.2.1 Global Veterinary Drug Raw Materials Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Veterinary Drug Raw Materials Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Veterinary Drug Raw Materials Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Veterinary Drug Raw Materials Sales Value by Application
  9. 5.3.1 Global Veterinary Drug Raw Materials Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Veterinary Drug Raw Materials Sales Value by Application (2021-2032)
  11. 5.3.3 Global Veterinary Drug Raw Materials Sales Value Share by Application (2021-2032)
6 Veterinary Drug Raw Materials Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Drug Raw Materials Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Drug Raw Materials Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Drug Raw Materials Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Drug Raw Materials Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Drug Raw Materials Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Drug Raw Materials Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Drug Raw Materials Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Drug Raw Materials Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Drug Raw Materials Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Drug Raw Materials Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Drug Raw Materials Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Drug Raw Materials Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Drug Raw Materials Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Drug Raw Materials Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Drug Raw Materials Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Drug Raw Materials Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Drug Raw Materials Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Drug Raw Materials Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Drug Raw Materials Sales Value Share by Country, 2025 VS 2032
7 Veterinary Drug Raw Materials Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Drug Raw Materials Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Drug Raw Materials Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Drug Raw Materials Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Drug Raw Materials Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Drug Raw Materials Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Drug Raw Materials Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Drug Raw Materials Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Drug Raw Materials Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Drug Raw Materials Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Drug Raw Materials Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Drug Raw Materials Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 China Animal Husbandry Co., Ltd.
  2. 8.1.1 China Animal Husbandry Co., Ltd. Company Information
  3. 8.1.2 China Animal Husbandry Co., Ltd. Business Overview
  4. 8.1.3 China Animal Husbandry Co., Ltd. Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 China Animal Husbandry Co., Ltd. Veterinary Drug Raw Materials Product Portfolio
  6. 8.1.5 China Animal Husbandry Co., Ltd. Recent Developments
  7. 8.2 victory creature
  8. 8.2.1 victory creature Company Information
  9. 8.2.2 victory creature Business Overview
  10. 8.2.3 victory creature Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 victory creature Veterinary Drug Raw Materials Product Portfolio
  12. 8.2.5 victory creature Recent Developments
  13. 8.3 Shandong Lukang
  14. 8.3.1 Shandong Lukang Company Information
  15. 8.3.2 Shandong Lukang Business Overview
  16. 8.3.3 Shandong Lukang Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Lukang Veterinary Drug Raw Materials Product Portfolio
  18. 8.3.5 Shandong Lukang Recent Developments
  19. 8.4 Rip Biotech
  20. 8.4.1 Rip Biotech Company Information
  21. 8.4.2 Rip Biotech Business Overview
  22. 8.4.3 Rip Biotech Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Rip Biotech Veterinary Drug Raw Materials Product Portfolio
  24. 8.4.5 Rip Biotech Recent Developments
  25. 8.5 Qilu Pharmaceutical
  26. 8.5.1 Qilu Pharmaceutical Company Information
  27. 8.5.2 Qilu Pharmaceutical Business Overview
  28. 8.5.3 Qilu Pharmaceutical Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Qilu Pharmaceutical Veterinary Drug Raw Materials Product Portfolio
  30. 8.5.5 Qilu Pharmaceutical Recent Developments
  31. 8.6 Qihui Pharmaceutical
  32. 8.6.1 Qihui Pharmaceutical Company Information
  33. 8.6.2 Qihui Pharmaceutical Business Overview
  34. 8.6.3 Qihui Pharmaceutical Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Qihui Pharmaceutical Veterinary Drug Raw Materials Product Portfolio
  36. 8.6.5 Qihui Pharmaceutical Recent Developments
  37. 8.7 Puluo Pharmaceutical
  38. 8.7.1 Puluo Pharmaceutical Company Information
  39. 8.7.2 Puluo Pharmaceutical Business Overview
  40. 8.7.3 Puluo Pharmaceutical Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Puluo Pharmaceutical Veterinary Drug Raw Materials Product Portfolio
  42. 8.7.5 Puluo Pharmaceutical Recent Developments
  43. 8.8 LianBern Pharmaceuticals
  44. 8.8.1 LianBern Pharmaceuticals Company Information
  45. 8.8.2 LianBern Pharmaceuticals Business Overview
  46. 8.8.3 LianBern Pharmaceuticals Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LianBern Pharmaceuticals Veterinary Drug Raw Materials Product Portfolio
  48. 8.8.5 LianBern Pharmaceuticals Recent Developments
  49. 8.9 Jiangsu Tianhe Pharmaceutical
  50. 8.9.1 Jiangsu Tianhe Pharmaceutical Company Information
  51. 8.9.2 Jiangsu Tianhe Pharmaceutical Business Overview
  52. 8.9.3 Jiangsu Tianhe Pharmaceutical Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu Tianhe Pharmaceutical Veterinary Drug Raw Materials Product Portfolio
  54. 8.9.5 Jiangsu Tianhe Pharmaceutical Recent Developments
  55. 8.10 Lasa Supergenerics Limited
  56. 8.10.1 Lasa Supergenerics Limited Company Information
  57. 8.10.2 Lasa Supergenerics Limited Business Overview
  58. 8.10.3 Lasa Supergenerics Limited Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lasa Supergenerics Limited Veterinary Drug Raw Materials Product Portfolio
  60. 8.10.5 Lasa Supergenerics Limited Recent Developments
  61. 8.11 Menadiona, S. L
  62. 8.11.1 Menadiona, S. L Company Information
  63. 8.11.2 Menadiona, S. L Business Overview
  64. 8.11.3 Menadiona, S. L Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Menadiona, S. L Veterinary Drug Raw Materials Product Portfolio
  66. 8.11.5 Menadiona, S. L Recent Developments
  67. 8.12 SeQuent Scientific Limited
  68. 8.12.1 SeQuent Scientific Limited Company Information
  69. 8.12.2 SeQuent Scientific Limited Business Overview
  70. 8.12.3 SeQuent Scientific Limited Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 SeQuent Scientific Limited Veterinary Drug Raw Materials Product Portfolio
  72. 8.12.5 SeQuent Scientific Limited Recent Developments
  73. 8.13 Guobang Pharmaceutical
  74. 8.13.1 Guobang Pharmaceutical Company Information
  75. 8.13.2 Guobang Pharmaceutical Business Overview
  76. 8.13.3 Guobang Pharmaceutical Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Guobang Pharmaceutical Veterinary Drug Raw Materials Product Portfolio
  78. 8.13.5 Guobang Pharmaceutical Recent Developments
  79. 8.14 Haisheng Pharmaceutical
  80. 8.14.1 Haisheng Pharmaceutical Company Information
  81. 8.14.2 Haisheng Pharmaceutical Business Overview
  82. 8.14.3 Haisheng Pharmaceutical Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Haisheng Pharmaceutical Veterinary Drug Raw Materials Product Portfolio
  84. 8.14.5 Haisheng Pharmaceutical Recent Developments
  85. 8.15 Hanjiang Pharmaceutical
  86. 8.15.1 Hanjiang Pharmaceutical Company Information
  87. 8.15.2 Hanjiang Pharmaceutical Business Overview
  88. 8.15.3 Hanjiang Pharmaceutical Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Hanjiang Pharmaceutical Veterinary Drug Raw Materials Product Portfolio
  90. 8.15.5 Hanjiang Pharmaceutical Recent Developments
  91. 8.16 Hui Sheng Biology
  92. 8.16.1 Hui Sheng Biology Company Information
  93. 8.16.2 Hui Sheng Biology Business Overview
  94. 8.16.3 Hui Sheng Biology Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Hui Sheng Biology Veterinary Drug Raw Materials Product Portfolio
  96. 8.16.5 Hui Sheng Biology Recent Developments
  97. 8.17 Jiuzhou Pharmaceutical
  98. 8.17.1 Jiuzhou Pharmaceutical Company Information
  99. 8.17.2 Jiuzhou Pharmaceutical Business Overview
  100. 8.17.3 Jiuzhou Pharmaceutical Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Jiuzhou Pharmaceutical Veterinary Drug Raw Materials Product Portfolio
  102. 8.17.5 Jiuzhou Pharmaceutical Recent Developments
  103. 8.18 Xinhua Pharmaceutical
  104. 8.18.1 Xinhua Pharmaceutical Company Information
  105. 8.18.2 Xinhua Pharmaceutical Business Overview
  106. 8.18.3 Xinhua Pharmaceutical Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Xinhua Pharmaceutical Veterinary Drug Raw Materials Product Portfolio
  108. 8.18.5 Xinhua Pharmaceutical Recent Developments
  109. 8.19 Shreeji Pharma Internationa
  110. 8.19.1 Shreeji Pharma Internationa Company Information
  111. 8.19.2 Shreeji Pharma Internationa Business Overview
  112. 8.19.3 Shreeji Pharma Internationa Veterinary Drug Raw Materials Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Shreeji Pharma Internationa Veterinary Drug Raw Materials Product Portfolio
  114. 8.19.5 Shreeji Pharma Internationa Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Drug Raw Materials Value Chain Analysis
  2. 9.1.1 Veterinary Drug Raw Materials Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Drug Raw Materials Sales Mode & Process
  6. 9.2 Veterinary Drug Raw Materials Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Drug Raw Materials Distributors
  9. 9.2.3 Veterinary Drug Raw Materials Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst